We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
CellMade Targets Inflammatory Biology Products and Services
Product News

CellMade Targets Inflammatory Biology Products and Services

CellMade Targets Inflammatory Biology Products and Services
Product News

CellMade Targets Inflammatory Biology Products and Services


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "CellMade Targets Inflammatory Biology Products and Services"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

www.cellmade.com looks set to become a primary resource for drug discovery and preclinical researchers working in inflammatory diseases.

Proprietary human primary co-culture models, primary human cells and stem cells, coupled with cytokine secretion assays and lipid bioanalysis, enables the CellMade team to identify and characterise the best biomarkers of early inflammatory response for drug discovery projects. These are critical tools to help companies to evaluate the safety and efficacy of their new drugs. In addition, the company uses its unique technology to develop companion tests for personalized medicine.

Ronald Bronsaer, Chief Executive Officer, CellMade said: “There is a growing need for effective companion tests for anti-inflammatory drugs, as patients and FDA concerns grow regarding the costs and unwanted side effects of the TNF-alpha antagonists. CellMade technology is being used to identify people who would benefit from such treatments, and to giving early warning signs of toxicity before clinical symptoms develop. The new website is a perfect vehicle to showcase our expertise and specialist knowledge in this area.”

Advertisement